Showing 1 - 8 results of 8 for search 'Mario Janini', query time: 0.04s Refine Results
  1. 1
    Analysis of the origin and evolutionary history of HIV-1 CRF28_BF and CRF29_BF reveals a decreasing prevalence in the AIDS epidemic of Brazil.

    Analysis of the origin and evolutionary history of HIV-1 CRF28_BF and CRF29_BF reveals a decreasing prevalence in the AIDS epidemic of Brazil. by Natalia Ristic, Jean Zukurov, Wagner Alkmim, Ricardo Sobhie Diaz, Luiz Mario Janini, Mario P S Chin

    Published 2011-03-01
    Get full text
    Article
  2. 2
    Correction: Analysis of the Origin and Evolutionary History of HIV-1 CRF28_BF and CRF29_BF Reveals a Decreasing Prevalence in the AIDS Epidemic of Brazil.

    Correction: Analysis of the Origin and Evolutionary History of HIV-1 CRF28_BF and CRF29_BF Reveals a Decreasing Prevalence in the AIDS Epidemic of Brazil. by Natalia Ristic, Jean Zukurov, Wagner Alkmim, Ricardo Sobhie Diaz, Luiz Mario Janini, Mario P. S. Chin

    Published 2011-01-01
    Get full text
    Article
  3. 3
    Surveillance programs for detection and characterization of emergent pathogens and antimicrobial resistance: results from the Division of Infectious Diseases, UNIFESP

    Surveillance programs for detection and characterization of emergent pathogens and antimicrobial resistance: results from the Division of Infectious Diseases, UNIFESP by Arnaldo L. Colombo, Mario Janini, Reinaldo Salomão, Eduardo A. S. Medeiros, Sergio B. Wey, Antonio C. C. Pignatari

    Published 2009-09-01
    Get full text
    Article
  4. 4
    Antiretroviral Drug-Resistance Mutations on the <i>Gag</i> Gene: Mutation Dynamics during Analytic Treatment Interruption among Individuals Experiencing Virologic Failure

    Antiretroviral Drug-Resistance Mutations on the <i>Gag</i> Gene: Mutation Dynamics during Analytic Treatment Interruption among Individuals Experiencing Virologic Failure by James R. Hunter, Domingos E. Matos dos Santos, Patricia Munerato, Luiz Mario Janini, Adauto Castelo, Maria Cecilia Sucupira, Hong-Ha M. Truong, Ricardo Sobhie Diaz

    Published 2022-05-01
    Get full text
    Article
  5. 5
    Fitness Cost of Antiretroviral Drug Resistance Mutations on the <i>pol</i> Gene during Analytical Antiretroviral Treatment Interruption among Individuals Experiencing Virological Failure

    Fitness Cost of Antiretroviral Drug Resistance Mutations on the <i>pol</i> Gene during Analytical Antiretroviral Treatment Interruption among Individuals Experiencing Virological F... by James R. Hunter, Domingos E. Matos dos Santos, Patricia Munerato, Luiz Mario Janini, Adauto Castelo, Maria Cecilia Sucupira, Hong-Ha M. Truong, Ricardo Sobhie Diaz

    Published 2021-11-01
    Get full text
    Article
  6. 6
    Faster HIV-1 disease progression among Brazilian individuals recently infected with CXCR4-utilizing strains.

    Faster HIV-1 disease progression among Brazilian individuals recently infected with CXCR4-utilizing strains. by Maria Cecilia Araripe Sucupira, Sabri Sanabani, Rodrigo M Cortes, Maria Teresa M Giret, Helena Tomiyama, Mariana M Sauer, Ester Cerdeira Sabino, Luiz Mario Janini, Esper Georges Kallas, Ricardo Sobhie Diaz

    Published 2012-01-01
    Get full text
    Article
  7. 7
    Nicotinamide activates latent HIV-1 ex vivo in ART suppressed individuals, revealing higher potency than the association of two methyltransferase inhibitors, chaetocin and BIX01294

    Nicotinamide activates latent HIV-1 ex vivo in ART suppressed individuals, revealing higher potency than the association of two methyltransferase inhibitors, chaetocin and BIX01294 by Sadia Samer, Muhammad Shoaib Arif, Leila Bertoni Giron, Jean Paulo Lopes Zukurov, James Hunter, Bruna Teresa Santillo, Gislene Namiyama, Juliana Galinskas, Shirley Vasconcelos Komninakis, Telma Miyuki Oshiro, Maria Cecilia Sucupira, Luiz Mario Janini, Ricardo Sobhie Diaz

    Published 2020-03-01
    Get full text
    Article
  8. 8
    Immunogenicity of personalized dendritic-cell therapy in HIV-1 infected individuals under suppressive antiretroviral treatment: interim analysis from a phase II clinical trial

    Immunogenicity of personalized dendritic-cell therapy in HIV-1 infected individuals under suppressive antiretroviral treatment: interim analysis from a phase II clinical trial by Marcella Vassão de Almeida Baptista, Laís Teodoro da Silva, Sadia Samer, Telma Miyuki Oshiro, Iart Luca Shytaj, Leila B. Giron, Nathalia Mantovani Pena, Nicolly Cruz, Gisele Cristina Gosuen, Paulo Roberto Abrão Ferreira, Edécio Cunha-Neto, Juliana Galinskas, Danilo Dias, Maria Cecilia Araripe Sucupira, Cesar de Almeida-Neto, Reinaldo Salomão, Alberto José da Silva Duarte, Luís Mário Janini, James R. Hunter, Andrea Savarino, Maria Aparecida Juliano, Ricardo Sobhie Diaz

    Published 2022-01-01
    Get full text
    Article

Search Tools: